FdaApplication
NDA 215422
Identifiers
- fda_app_no: NDA215422
Properties
| Property | Value |
|---|---|
| applicant_name | STRIDES PHARMA INTERNATIONAL AG |
| application_type | NDA |
| approval_date | 2021-11-22 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LYVISPAH | BACLOFEN | 20MG/PACKET | GRANULE;ORAL |
| LYVISPAH | BACLOFEN | 5MG/PACKET | GRANULE;ORAL |
| LYVISPAH | BACLOFEN | 10MG/PACKET | GRANULE;ORAL |
3 products